CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 95,377	$ 40,540
Restricted cash	15,784	13,593
Patient accounts receivable	278,785	296,785
Prepaid expenses	13,774	11,628
Other current assets	22,824	26,415
Total current assets	426,544	388,961
Property and equipment, net of accumulated depreciation of $90,523 and $101,364	36,399	16,026
Operating lease right of use assets	85,142	102,856
Goodwill	1,244,679	1,287,399
Intangible assets, net of accumulated amortization of $17,714 and $14,604	104,744	101,167
Other assets	84,894	79,836
Total assets	1,982,402	1,976,245
Current liabilities:
Accounts payable	38,557	43,735
Payroll and employee benefits	123,234	125,387
Accrued expenses	137,359	137,390
Termination fee paid by UnitedHealth Group	106,000	0
Current portion of long-term obligations	31,465	15,496
Current portion of operating lease liabilities	25,786	33,521
Total current liabilities	462,401	355,529
Long-term obligations, less current portion	369,896	419,420
Operating lease liabilities, less current portion	59,634	69,504
Deferred income tax liabilities	28,085	20,411
Other long-term obligations	1,629	4,808
Total liabilities	921,645	869,672
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,030,397 and 37,891,186 shares issued; 32,608,325 and 32,511,465 shares outstanding	38	38
Additional paid-in capital	768,789	755,063
Treasury stock, at cost, 5,422,072 and 5,379,721 shares of common stock	(464,688)	(461,200)
Retained earnings	702,643	757,672
Total Amedisys, Inc. stockholders’ equity	1,006,782	1,051,573
Noncontrolling interests	53,975	55,000
Total equity	1,060,757	1,106,573
Total liabilities and equity	$ 1,982,402	$ 1,976,245